Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREApproved for protection of healthy dogs against canine distemper, adenovirus (Type 1), CPIV and CPV.
LEARN MOREFor the vaccination of healthy nursing piglets against rotaviral diarrhea.
LEARN MOREFor the vaccination of healthy pregnant swine to provide passive immunity against rotaviral diarrhea, colibacillosis and enterotoxemia due to…
LEARN MOREFor the vaccination of healthy swine 3 weeks of age or older against respiratory form of the disease caused by Porcine Reproductive and Respiratory…
LEARN MOREFor use in healthy swine as an aid in the control of ileitis caused by Lawsonia intracellularis, an aid in the reduction of colonization by Lawsonia, and an aid…
LEARN MOREAn aid in the prevention of pneumonia, diarrhea, septicemia and mortality caused by Salmonella Choleraesuis and as an aid in control of disease caused by…
LEARN MOREFor the vaccination of healthy puppies for the prevention of disease caused by canine distemper virus and CPV.
LEARN MOREFirst and only non-adjuvanted feline leukemia virus (FeLV) vaccine built on RNA particle technology
LEARN MOREFirst and only canine flu vaccine built on RNA particle technology
LEARN MOREFor vaccination of healthy dogs 8 weeks or older against Borrelia burgdorferi. Duration of Immunity is at least 1 year.
LEARN MORE